Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05556395

Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to gain a better understanding of why some individuals who have suffered a stroke experience post-stroke cognitive decline. Specifically this study is testing whether global disruption of the blood-brain barrier detected at the time of the stroke is informative about the risk of post-stroke cognitive decline over the next 3 years.

Detailed description

It is well known that ischemic stroke is a risk factor for developing dementia. Prior studies have shown that after a stroke, there can be a change in the trajectory of cognitive performance with acceleration of decline. The mechanism of this phenomenon has not been established. It is known that vascular changes in the brain, referred to as cerebral small vessel disease, are associated with cognitive decline and dementia. Cerebral small vessel disease is readily seen on MRI scans of the brain, and the larger the burden of these findings, the higher the risk of cognitive deficits. Disruption of the blood-brain barrier has been implicated in the development of the changes seen on MRI. Acute stroke has been shown to disrupt the blood-brain barrier, even in parts of the brain not directly affect by the stroke. The investigators hypothesize that when there is diffuse blood-brain barrier disruption in response to an acute stroke it sets off a cascade of changes in the brain that lead to post-stroke cognitive decline.

Conditions

Timeline

Start date
2022-04-01
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2022-09-27
Last updated
2025-09-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05556395. Inclusion in this directory is not an endorsement.